Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 1;41(5):e208-e215.
doi: 10.1097/INF.0000000000003494.

Severe Recurrent Bacterial Pneumonia Among Children Living With HIV

Affiliations

Severe Recurrent Bacterial Pneumonia Among Children Living With HIV

David C Boettiger et al. Pediatr Infect Dis J. .

Abstract

Background: Bacterial pneumonia imparts a major morbidity and mortality burden on children living with HIV, yet effective prevention and treatment options are underutilized. We explored clinical factors associated with severe recurrent bacterial pneumonia among children living with HIV.

Methods: Children enrolled in the TREAT Asia Pediatric HIV Observational Database were included if they started antiretroviral therapy (ART) on or after January 1st, 2008. Factors associated with severe recurrent bacterial pneumonia were assessed using competing-risk regression.

Results: A total of 3,944 children were included in the analysis; 136 cases of severe recurrent bacterial pneumonia were reported at a rate of 6.5 [95% confidence interval (CI): 5.5-7.7] events per 1,000 patient-years. Clinical factors associated with severe recurrent bacterial pneumonia were younger age [adjusted subdistribution hazard ratio (aHR): 4.4 for <5 years versus ≥10 years, 95% CI: 2.2-8.4, P < 0.001], lower weight-for-age z-score (aHR: 1.5 for <-3.0 versus >-2.0, 95% CI: 1.1-2.3, P = 0.024), pre-ART diagnosis of severe recurrent bacterial pneumonia (aHR: 4.0 versus no pre-ART diagnosis, 95% CI: 2.7-5.8, P < 0.001), past diagnosis of symptomatic lymphoid interstitial pneumonitis or chronic HIV-associated lung disease, including bronchiectasis (aHR: 4.8 versus no past diagnosis, 95% CI: 2.8-8.4, P < 0.001), low CD4% (aHR: 3.5 for <10% versus ≥25%, 95% CI: 1.9-6.4, P < 0.001) and detectable HIV viral load (aHR: 2.6 versus undetectable, 95% CI: 1.2-5.9, P = 0.018).

Conclusions: Children <10-years-old and those with low weight-for-age, a history of respiratory illness, low CD4% or poorly controlled HIV are likely to gain the greatest benefit from targeted prevention and treatment programs to reduce the burden of bacterial pneumonia in children living with HIV.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1.
FIGURE 1.
Kaplan-Meier curves showing clinical factors associated with severe recurrent bacterial pneumonia. *Symptomatic lymphoid interstitial pneumonitis or chronic HIV-associated lung disease including bronchiectasis; ART, antiretroviral therapy.

References

    1. Prasitsuebsai W, Kariminia A, Puthanakit T, et al. Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database. Pediatr Infect Dis J. 2014;33:747–752. - PMC - PubMed
    1. Sohn AH, Lumbiganon P, Kurniati N, et al.; for IeDEA Asia-Pacific. Determining standardized causes of death of infants, children, and adolescents living with HIV in Asia. AIDS. 2020;34:1527–1537. - PMC - PubMed
    1. Calder D, Qazi S. Evidence behind the WHO guidelines: hospital care for children: what is the aetiology of pneumonia in HIV-infected children in developing countries? J Trop Pediatr. 2009;55:219–224. - PubMed
    1. Madhi SA, Levine OS, Hajjeh R, et al. Vaccines to prevent pneumonia and improve child survival. Bull World Health Organ. 2008;86:365–372. - PMC - PubMed
    1. Bliss SJ, O’Brien KL, Janoff EN, et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis. 2008;8:67–80. - PubMed

Publication types

MeSH terms

Substances